FIELD: medicine.
SUBSTANCE: invention relates to medicine and can be used for pre-operation preparation of patients with stomach disease of ulcer or duodenum associated with Helicobacter pylori. Patient is given conventional antihelicobacterial therapy. Starting with the third day of therapy, medication leukinferon is introduced daily. Dose constitutes 2.0 ml intramuscularly one time per day. Duration of course is 5 days. After that antihelicobacterial therapy is stopped. Intramuscular introduction of medication leukinferon is continued in the same dose for 4 days every second day.
EFFECT: method makes it possible to significantly reduce the number of post-operation complications.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING HELICOBACTER PYLORI-ASSOCIATED ULCEROUS GASTRIC AND DUODENAL DISEASE | 2006 |
|
RU2308949C1 |
METHOD OF TREATMENT OF PEPTIC ULCER OF STOMACH AND DUODENUM, ASSOCIATED WITH Helicobacter pylori | 2007 |
|
RU2352346C2 |
METHOD FOR PREVENTION OF STOMACH ULCERS IN RENAL OPERATIONS | 2016 |
|
RU2711207C2 |
COMPLEX THERAPY METHOD FOR TREATING DUODENAL PEPTIC ULCER DISEASES ASSOCIATED WITH HELICOBACTER PYLORI | 2006 |
|
RU2318514C2 |
METHOD FOR TREATING GASTRIC AND DUODENAL ULCEROUS DISEASE | 2005 |
|
RU2304967C2 |
METHOD OF HELICOBACTER PYLORI INFECTION DIAGNOSTICS IN PATIENTS WITH SURGICAL PATHOLOGY OF ABDOMINAL CAVITY ORGANS | 2009 |
|
RU2440583C2 |
METHOD FOR TREATMENT OF STOMACH AND DUODENUM ULCEROUS DISEASE | 2006 |
|
RU2294204C1 |
METHOD OF TREATING CHRONIC GASTRODUODENITIS ASSOCIATED WITH INFECTION CAUSED BY BACTERIA Helicobacter pylori IN ALLERGIC DISEASES | 2011 |
|
RU2472498C1 |
METHOD FOR TREATING THE CASES OF GASTRIC AND DUODENAL PEPTIC ULCER | 2004 |
|
RU2250767C1 |
METHOD FOR PREVENTING EROSIVE AND ULCERATIVE LESIONS OF STOMACH AND DUODENUM DURING CHEMOTHERAPY | 2023 |
|
RU2806313C1 |
Authors
Dates
2012-04-27—Published
2011-01-20—Filed